Posts by: Maria Verissimo, MSc

News

Researchers at Queen Mary University of London have discovered that the blood levels of circulating tumor cells and megakaryocytes (platelet-producing cells) may help identify patients with aggressive metastatic prostate cancer, allowing them to ... Read more

June 28, 2017June 28, 2017

First N.Z. Prostate Cancer Patient Treated With SpaceOAR Technology

News

New Zealand’s Kathleen Kilgour Centre (KKC) has treated the country’s first patient with Augmenix‘s SpaceOAR system, a medical device that protects men from rectal complications after prostate cancer radiation therapy. Because the prostate and the rectum ... Read more

June 7, 2017June 7, 2017

Adding Zytiga, Prednisone to ADT Improves Outcomes for Newly Diagnosed, High-risk Metastatic Prostate Cancer Patients

News

Newly diagnosed men with high-risk metastatic hormone-naive prostate cancer (mHNPC) lived significantly healthier, longer lives when doctors added Zytiga (abiraterone acetate) and prednisone to their androgen deprivation therapy (ADT), according to results ... Read more